A few months back, we set out to refresh our appearance and bring you a more interactive and easier to navigate website. Today we are pleased to announce the launch of the updated Maverix Biomics website. We welcome you to explore the new site as we continue to add more content, resources, videos, and information […]
Enhanced design allows comparison of side-by-side results from HTSeq/DESeq and Cufflinks
San Mateo CA June 18, 2014: Maverix Biomics Inc., a leading genomic analysis software company, today announced improved functionality for RNA-seq differential expression analysis on the Maverix Analytic Platform, an industry leading cloud-based solution that enables life science researchers […]
Integration of Ingenuity® Pathway Analysis and Maverix Analytic Platform Streamlines Biological Interpretation of RNA-seq Studies
San Mateo CA April 1, 2014: Maverix Biomics Inc. today announced that the company has extended its strategic co-marketing agreement with QIAGEN by offering additional technology that enables researchers to transition from raw […]
Maverix Analytic Platform to be Used for Analysis and Hosting of Community of Discovery
San Mateo CA January 28, 2014: Maverix Biomics, Inc. is pleased to announce that it has received a $100,000 order from the University of Missouri for the analysis of feline genomes as part of the 99 Lives Cat Whole Genome Sequencing Initiative, […]
Prominent Silicon Valley Information Technology Investors at Forefront of Life Sciences Cloud Computing for Next Generation Sequencing and Genomics
San Mateo CA January 7, 2014: Maverix Biomics, Inc., a leading provider of software for next-generation sequencing genomic data analysis, today announced that it has closed a $6 million Series A funding round. The company’s pioneering flagship offering, […]
Maverix Analytic Platform complements QIAGEN’s Ingenuity® iReport™ for seamless NGS analysis workflow to enable high-quality insights
Phoenix AZ November 13, 2013: Maverix Biomics Inc., today announced at the Association of Molecular Pathology (AMP) 2013 Annual Meeting in Phoenix, Arizona that the company has signed a non-exclusive strategic co-marketing agreement with QIAGEN to streamline the interpretation of raw next-generation […]
Data analysis platform enables rapid detection of unique small RNA signatures in tumor-derived samples
Boston MA September 24, 2013: Maverix Biomics, Inc. will present at the NGS for Cancer Drug Development meeting held on September 24-26, 2013 in Boston, Massachusetts. Todd Lowe PhD, Chief Scientist of Maverix Biomics, will lead a session at 9:30 a.m. Thursday, September 26 […]
Exosome RNA Next Generation Sequencing and Analytics Accelerate Pace of Discovery
San Mateo CA May 6, 2013: Maverix Biomics, Inc. and System Biosciences, Inc. (SBI) publicly announced the launch of their complete exosome RNA sequence analytics solution today at the Biomarkers & Diagnostics World Congress 2013 held in Philadelphia, Pennsylvania.
The combination of products and services from both […]
Making Complex Next Generation Sequencing Analytics Easy for Life Sciences Researchers
Marco Island FL February 20, 2013: Maverix Biomics, Inc. today marks the 100th day of the successful launch and adoption by revenue-generating customers of the Maverix Analytic Platform at the Advances in Genome Biology and Technology (AGBT 2013) meeting being held on […]
New Program Provides Researchers With NGS Data Analytics Capability
San Mateo CA January 14, 2013: Maverix Biomics is pleased to announce the availability of the MAGNET (Maverix Academic Grants for NGS Exploration Tools) program for academic and non-profit life sciences researchers. MAGNET grants eliminate the economic barrier for researchers to store, analyze, explore, and visualize Next Generation Sequencing […]